Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol combined with remimazolam tosylate for intravenous anesthesia in gastric cancer surgery
ChiCTR2100043993Phase 4Recruiting
- Sponsor
- Linyi People's Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and remimazolam in gastric cancer (GC) (4 arms), sponsored by Linyi People's Hospital. Primary endpoints: Cardiac output and Systemic vascular resistance. Started Mar 2021; status: recruiting.
02
Drugs
propofolremimazolam
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2100043993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043993.